Shnider BI, Salvin LG, Schneiderman MA, Colsky J, Owens AH Jr,+OWENS AH JR, Krant MJ, Miller SP, Frei E 3d,+FREI E III, Hall TC, Spurr CL, McIntyre OR,+MACINTYRE OR, Hoogstraten B, Holland JF: The use of mechlorethamine, cyclophosphamide, and uracil mustard in neoplastic disease: a cooperative study.
D001943:Breast Neoplasms / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003110:Colonic Neoplasms / Q000188:drug therapy; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008297:Male; D008466:Mechlorethamine / Q000627:therapeutic use*; D009369:Neoplasms / Q000188:drug therapy*; D010051:Ovarian Neoplasms / Q000188:drug therapy; D011471:Prostatic Neoplasms / Q000188:drug therapy; D012004:Rectal Neoplasms / Q000188:drug therapy; D012509:Sarcoma / Q000188:drug therapy; D014499:Uracil Mustard / Q000627:therapeutic use*; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy
D008466:Mechlorethamine; D003520:Cyclophosphamide; D014499:Uracil Mustard